|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US6872868B1
(en)
|
1981-06-12 |
2005-03-29 |
Ohio University |
Transgenic mammals
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4965198A
(en)
|
1985-12-24 |
1990-10-23 |
Konica Corporation |
Monoclonal antibody and method of manufacturing hybridoma producing the same
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
IN164232B
(enExample)
|
1986-04-11 |
1989-02-04 |
Hoechst India |
|
|
US4695198A
(en)
|
1986-05-23 |
1987-09-22 |
Chevron Research Company |
Lip-type sealing system for a removable bottom founded structure
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5059680A
(en)
|
1986-11-24 |
1991-10-22 |
Centocor, Inc. |
Method of isolating ca 125 antigen
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
CA1340927C
(en)
|
1987-10-09 |
2000-03-14 |
Peter S. Linsley |
Method for increasing the sensitivity of assays for target ligand
|
|
IT1212041B
(it)
|
1987-11-02 |
1989-11-08 |
Fidia Farmaceutici |
Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
|
|
JPH02486A
(ja)
|
1987-11-13 |
1990-01-05 |
Mect Corp |
遊離ｎ−アセチルノイラミン酸を認識するモノクローナル抗体
|
|
US4978745A
(en)
|
1987-11-23 |
1990-12-18 |
Centocor, Inc. |
Immunoreactive heterochain antibodies
|
|
US4975369A
(en)
|
1988-04-21 |
1990-12-04 |
Eli Lilly And Company |
Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
|
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP1541682A3
(en)
|
1988-09-02 |
2005-07-06 |
Dyax Corp. |
Generation and selection of recombinant varied binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9012995D0
(en)
|
1990-06-11 |
1990-08-01 |
Celltech Ltd |
Multivalent antigen-binding proteins
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
DE69130709T3
(de)
|
1990-10-05 |
2005-12-22 |
Celldex Therapeutics, Inc. |
Gezielte immunostimulierung mit bispezifischen stoffen
|
|
EP0557300B1
(en)
|
1990-10-29 |
1997-11-19 |
Chiron Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE69214709T2
(de)
|
1991-04-26 |
1997-02-20 |
Surface Active Ltd |
Neue Antikörper und Verfahren zu ihrer Verwendung
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
JPH07501451A
(ja)
|
1991-11-25 |
1995-02-16 |
エンゾン・インコーポレイテッド |
多価抗原結合タンパク質
|
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
EP0627940B1
(en)
|
1992-03-05 |
2003-05-07 |
Board of Regents, The University of Texas System |
Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
DK0563475T3
(da)
|
1992-03-25 |
2000-09-18 |
Immunogen Inc |
Konjugater af cellebindende midler og derivater af CC-1065
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5951983A
(en)
|
1993-03-05 |
1999-09-14 |
Universite Catholique De Louvain |
Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies
|
|
US20030108548A1
(en)
|
1993-06-01 |
2003-06-12 |
Bluestone Jeffrey A. |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
DE69531148T2
(de)
|
1994-01-31 |
2004-04-29 |
Trustees Of Boston University, Boston |
Bibliotheken aus polyklonalen antikörpern
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US5919652A
(en)
|
1994-11-09 |
1999-07-06 |
The Regents Of The University Of California |
Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
|
|
US5710038A
(en)
|
1994-11-25 |
1998-01-20 |
Universite De Montreal |
Primary cultures of normal and tumoral human ovarian epithelium
|
|
US5811510A
(en)
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5733920A
(en)
|
1995-10-31 |
1998-03-31 |
Mitotix, Inc. |
Inhibitors of cyclin dependent kinases
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
US5849733A
(en)
|
1996-05-10 |
1998-12-15 |
Bristol-Myers Squibb Co. |
2-thio or 2-oxo flavopiridol analogs
|
|
JP2000514919A
(ja)
|
1996-07-03 |
2000-11-07 |
ミレニアム ファーマシューティカルズ，インコーポレイテッド |
少くとも三分枝の連鎖オリゴ糖を持つ癌特異的抗原の検定による癌の検出
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US6348584B1
(en)
|
1996-10-17 |
2002-02-19 |
John Edward Hodgson |
Fibronectin binding protein compounds
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
SI0970126T1
(en)
|
1997-04-14 |
2001-08-31 |
Micromet Ag |
Novel method for the production of antihuman antigen receptors and uses thereof
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
WO1998056915A2
(en)
|
1997-06-12 |
1998-12-17 |
Research Corporation Technologies, Inc. |
Artificial antibody polypeptides
|
|
EP1015616A2
(en)
|
1997-09-19 |
2000-07-05 |
Dana Farber Cancer Institute, Inc. |
Intrabody-mediated control of immune reactions
|
|
WO1999037751A1
(en)
|
1998-01-23 |
1999-07-29 |
Imclone Systems Incorporated |
Purified populations of stem cells
|
|
WO2000023573A2
(en)
|
1998-10-20 |
2000-04-27 |
City Of Hope |
Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
|
|
US20030170249A1
(en)
|
1999-02-19 |
2003-09-11 |
Hakomori Sen-Itiroh |
Vaccines directed to cancer-associated carbohydrate antigens
|
|
US20020012660A1
(en)
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
GB2344886B
(en)
|
1999-03-10 |
2000-11-01 |
Medical Res Council |
Selection of intracellular immunoglobulins
|
|
WO2000076319A1
(en)
|
1999-06-16 |
2000-12-21 |
Biocrystal Ltd. |
Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
|
|
EP1244705B1
(en)
|
1999-12-06 |
2010-01-27 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
|
|
US20030008813A1
(en)
|
1999-12-17 |
2003-01-09 |
Felgner Philip L. |
Intracellular protein delivery compositions and methods of use
|
|
WO2001043778A1
(en)
|
1999-12-17 |
2001-06-21 |
Gene Therapy Systems, Inc. |
Use of cationic lipids for intracellular protein delivery
|
|
US7279294B2
(en)
|
2000-04-03 |
2007-10-09 |
The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih |
Tumor markers in ovarian cancer
|
|
IT1317922B1
(it)
|
2000-10-24 |
2003-07-15 |
S I S S A Scuola Internaz Supe |
Metodo per identificare in vivo epitopi intracellulari.
|
|
CA2425862C
(en)
|
2000-11-07 |
2013-01-22 |
City Of Hope |
Cd19-specific redirected immune cells
|
|
AU2002338446A1
(en)
|
2001-01-23 |
2002-11-05 |
University Of Rochester Medical Center |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
WO2002067849A2
(en)
|
2001-02-26 |
2002-09-06 |
Sabina Glozman |
Systems devices and methods for intrabody targeted delivery and reloading of therapeutic agents
|
|
GB0108165D0
(en)
|
2001-03-31 |
2001-05-23 |
Univ Manchester |
Intracellular analysis
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
EP1383889B1
(en)
|
2001-04-30 |
2014-11-19 |
RBC Biotechnology, Inc. |
Modified organs and cells for xenotransplantation
|
|
WO2002088334A1
(en)
|
2001-04-30 |
2002-11-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
KR100486784B1
(ko)
|
2001-05-22 |
2005-04-29 |
김하형 |
솔비나무로 부터 추출된 렉틴 단백질, 그의 제조방법 및용도
|
|
WO2002094199A2
(en)
|
2001-05-24 |
2002-11-28 |
Immucom Inc. |
METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
|
|
US6814734B2
(en)
|
2001-06-18 |
2004-11-09 |
Sdgi Holdings, Inc, |
Surgical instrumentation and method for forming a passage in bone having an enlarged cross-sectional portion
|
|
CA2453662A1
(en)
|
2001-07-19 |
2003-01-30 |
Stefan Ewert |
Modification of human variable domains
|
|
AU2002355477B2
(en)
|
2001-08-03 |
2008-09-25 |
Medical Research Council |
Method of identifying a consensus sequence for intracellular antibodies
|
|
EP1419176A2
(en)
|
2001-08-17 |
2004-05-19 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Glycoconjugates of sialic acid derivates, methods for their production and use thereof
|
|
EP1442063A2
(de)
|
2001-11-09 |
2004-08-04 |
Hexal Biotech Forschungsgmbh |
Anti-n-glykolyl-neuraminsäure-antikörper und ihre verwendung zur bestimmung von glykoproteinen
|
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
DE60303009T2
(de)
|
2002-01-22 |
2006-07-13 |
Warner-Lambert Co. Llc |
2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-one
|
|
GB0201611D0
(en)
|
2002-01-24 |
2002-03-13 |
Grosveld Frank |
Transgenic animal
|
|
GB0226723D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Antibodies for in vitro use
|
|
AU2003219277A1
(en)
|
2002-03-14 |
2003-09-29 |
Medical Research Council |
Intracellular antibodies
|
|
GB0226727D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Intrabodies
|
|
AU2003222171A1
(en)
|
2002-04-05 |
2003-10-27 |
Selective Genetics, Inc. |
Compositions and methods for portal specific gene delivery and treatment of infection
|
|
EP2332989B1
(en)
|
2002-05-22 |
2015-04-01 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
GB0226731D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Method for generating immunoglobulin genes
|
|
GB0226729D0
(en)
|
2002-11-15 |
2002-12-24 |
Medical Res Council |
Intracellular antibodies
|
|
CA2506128A1
(en)
|
2002-11-15 |
2004-06-03 |
Medical Research Council |
Anti-activated ras antibodies
|
|
ITRM20020588A1
(it)
|
2002-11-21 |
2004-05-22 |
Lay Line Genomics Spa |
Metodo per isolare anticorpi intracellulari neutralizzanti di interazioni proteiche.
|
|
EP1482309A1
(en)
|
2003-05-07 |
2004-12-01 |
Institut Curie |
Means for detecting protein conformation and applications thereof
|
|
JP4053073B2
(ja)
|
2003-07-11 |
2008-02-27 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
選択的ｃｄｋ４阻害剤のイセチオン酸塩
|
|
EP1651955A4
(en)
|
2003-07-15 |
2007-11-21 |
Univ California |
PROCESS FOR THE DETECTION AND ANALYSIS OF N-GLYCOLYLNEURAMIC ACID (NEU5GC) IN BIOLOGICAL MATERIALS
|
|
ITMI20031909A1
(it)
|
2003-10-03 |
2005-04-04 |
Keryos Spa |
Linee cellulari di mammifero modificate per la produzione di glicoproteine ricombinanti.
|
|
AU2004309373A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
EP1723422A2
(en)
|
2004-03-05 |
2006-11-22 |
The Scripps Research Institute |
High throughput glycan microarrays
|
|
ATE537189T1
(de)
|
2004-04-30 |
2011-12-15 |
Inst Nat Sante Rech Med |
Anti-tfr-antikörper
|
|
KR100620554B1
(ko)
*
|
2004-06-05 |
2006-09-06 |
한국생명공학연구원 |
Ｔａｇ-72에 대한 인간화 항체
|
|
CA2571431A1
(en)
|
2004-06-24 |
2006-01-05 |
The Scripps Research Institute |
Arrays with cleavable linkers
|
|
US7638467B2
(en)
|
2004-08-03 |
2009-12-29 |
Intevep, S.A. |
Reversible gelling system and method using same during well treatments
|
|
EP2422811A2
(en)
|
2004-10-27 |
2012-02-29 |
MedImmune, LLC |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
WO2006068758A2
(en)
|
2004-11-19 |
2006-06-29 |
The Scripps Research Institute |
Detection, prevention and treatment of breast cancer
|
|
US7585503B2
(en)
*
|
2005-03-31 |
2009-09-08 |
Nahid Razi |
Method for detecting multi-drug resistance
|
|
WO2006116260A2
(en)
|
2005-04-26 |
2006-11-02 |
Medimmune, Inc. |
Modulation of antibody effector function by hinge domain engineering
|
|
US20090041783A1
(en)
|
2005-04-28 |
2009-02-12 |
Mochida Pharmaceutical Co., Ltd. |
Anti-platelet membrane glycoprotein vi monoclonal antibody
|
|
AU2006254862B2
(en)
|
2005-06-08 |
2011-04-07 |
The Regents Of The University Of California |
Elimination of N-glycolylneuraminic acid from mammalian products for human use
|
|
AU2006283726C1
(en)
|
2005-08-24 |
2015-05-07 |
Immunogen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
|
MX2008007682A
(es)
|
2005-12-20 |
2008-10-23 |
Sbi Biotech Co Ltd |
Anticuerpo anti-ilt7.
|
|
WO2010002478A2
(en)
|
2008-07-03 |
2010-01-07 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
WO2007079448A2
(en)
|
2006-01-03 |
2007-07-12 |
University Of Georgia Research Foundation, Inc. |
Three component carbohydrate vaccine
|
|
ES2366552T3
(es)
|
2006-01-13 |
2011-10-21 |
Institut Pasteur |
Síntesis enzimática a gran escala de glicoconjugados de mucina y sus aplicaciones en inmunología.
|
|
EP2389946A1
(en)
|
2006-03-23 |
2011-11-30 |
Novartis AG |
Anti-tumor cell antigen antibody therapeutics
|
|
WO2007116779A1
(ja)
|
2006-03-31 |
2007-10-18 |
Mochida Pharmaceutical Co., Ltd. |
新規血小板活性化マーカー及びその測定方法
|
|
US20070265170A1
(en)
|
2006-05-15 |
2007-11-15 |
Ola Blixt |
Detection, prevention and treatment of ovarian cancer
|
|
GB0613209D0
(en)
|
2006-07-03 |
2006-08-09 |
Ucb Sa |
Methods
|
|
US8440798B2
(en)
|
2006-10-04 |
2013-05-14 |
Københavns Universitet |
Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
|
|
WO2008070363A2
(en)
|
2006-10-31 |
2008-06-12 |
Domantis Limited |
Intrabodies
|
|
EP2082234B1
(en)
|
2006-11-02 |
2012-10-03 |
Procognia (Israel) Ltd. |
Methods for screening for therapeutic molecules and use of the molecules therefrom
|
|
WO2009018438A1
(en)
|
2007-07-31 |
2009-02-05 |
Cornell Research Foundation, Inc. |
Protein discovery using intracellular ribosome display
|
|
EP2014302A1
(en)
|
2007-07-12 |
2009-01-14 |
Institut Curie |
An antibody specific for the Tn antigen for the treatment of cancer
|
|
WO2009035494A2
(en)
|
2007-07-30 |
2009-03-19 |
The Scripps Research Institute |
Methods for producing anti-glycan antibodies, vaccines and methods for treating cancer or infectious disease
|
|
FI20070853A0
(fi)
|
2007-11-09 |
2007-11-09 |
Glykos Finland Oy |
Glykaania sitovat monoklonaaliset vasta-aineet
|
|
UA104132C2
(en)
|
2007-11-13 |
2014-01-10 |
Тева Биофармасьютикалз Юесей, Инк. |
Humanized antibodies against tl1a
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
US20120027813A1
(en)
|
2008-02-22 |
2012-02-02 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines for pediatric use
|
|
US8298773B2
(en)
|
2008-05-02 |
2012-10-30 |
Marko Vuskovic |
Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes
|
|
US9226934B2
(en)
|
2008-06-02 |
2016-01-05 |
The University Of Tokyo |
Anti-cancer drug
|
|
EP2143735A1
(en)
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
|
FI20095418A0
(fi)
|
2009-04-16 |
2009-04-16 |
Suomen Punainen Risti Veripalv |
Kryptinen subpopulaatio
|
|
KR101353857B1
(ko)
|
2008-08-22 |
2014-01-21 |
노파르티스 아게 |
Ｃｄｋ 억제제로서 피롤로피리미딘 화합물
|
|
US20120045816A1
(en)
|
2008-09-09 |
2012-02-23 |
Sialix, Inc. |
Novel Glycosylated Polypeptides
|
|
CN102197131A
(zh)
|
2008-09-09 |
2011-09-21 |
加利福尼亚大学董事会 |
通过代谢竞争除去污染性的非人唾液酸
|
|
WO2012118928A2
(en)
|
2011-03-01 |
2012-09-07 |
University Of Georgia Research Foundation, Inc. |
Glycoprofiling with multiplexed suspension arrays
|
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
|
US20100178292A1
(en)
|
2009-01-12 |
2010-07-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cryptic glycan markers and applications thereof
|
|
US8669085B2
(en)
|
2009-02-05 |
2014-03-11 |
Ut-Battelle, Llc |
Transformation of gram positive bacteria by sonoporation
|
|
KR20120057588A
(ko)
|
2009-05-28 |
2012-06-05 |
메르사나 테라퓨틱스, 인코포레이티드 |
가변 속도 방출 링커를 포함하는 폴리알 약물 접합체
|
|
US8399624B1
(en)
|
2009-06-25 |
2013-03-19 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Acceptor framework for CDR grafting
|
|
SG176947A1
(en)
|
2009-07-03 |
2012-01-30 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
|
EP2275442A1
(en)
|
2009-07-06 |
2011-01-19 |
Ludwig-Maximilians-Universität München |
Detection and vizualization of the cell cycle in living cells
|
|
ES2624835T3
(es)
|
2009-08-06 |
2017-07-17 |
Immunas Pharma, Inc. |
Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos
|
|
EP2287202A1
(en)
|
2009-08-07 |
2011-02-23 |
Dublin City University |
Anti-sialic acid antibody molecules
|
|
JP5934099B2
(ja)
|
2009-10-01 |
2016-06-15 |
アメリカ合衆国 |
抗血管内皮増殖因子受容体−２キメラ抗原受容体及び癌の治療のためのその使用
|
|
MX2012006406A
(es)
|
2009-12-04 |
2012-07-25 |
Genentech Inc |
Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
|
|
WO2011088385A2
(en)
|
2010-01-15 |
2011-07-21 |
The Regents Of The University Of California |
Compositions and methods for detecting cancer
|
|
EP2347769A1
(en)
|
2010-01-20 |
2011-07-27 |
Glycotope GmbH |
Cancer stem cell markers and uses thereof
|
|
US8883977B2
(en)
|
2010-04-28 |
2014-11-11 |
Shionogi & Co., Ltd. |
MUC1 antibody
|
|
WO2011139974A2
(en)
|
2010-05-03 |
2011-11-10 |
Abbott Laboratories |
Anti-pai-1 antibodies and methods of use thereof
|
|
CN103209701B
(zh)
|
2010-06-11 |
2016-08-03 |
乔治亚大学研究基金公司 |
免疫原性疫苗
|
|
AU2011279158B2
(en)
|
2010-07-13 |
2015-07-09 |
Ultragenyx Pharmaceutical Inc. |
Method and formulations for treating sialic acid deficiencies
|
|
EP2407487A1
(en)
|
2010-07-14 |
2012-01-18 |
F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. |
Multispecific modular antibody
|
|
KR102344129B1
(ko)
|
2010-10-08 |
2021-12-30 |
시티 오브 호프 |
메디토프를 위한 단일클론 항체 프레임워크 결합 계면, 메디토프 전달 시스템 및 이의 사용 방법
|
|
AR083797A1
(es)
|
2010-11-10 |
2013-03-20 |
Novartis Ag |
Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2012094627A2
(en)
|
2011-01-06 |
2012-07-12 |
The Johns Hopkins University |
Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
|
|
MX365095B
(es)
|
2011-02-01 |
2019-05-22 |
Hibm Res Group Inc |
Métodos y composiciones para incrementar la producción de ácido siálico y tratar condiciones de enfermedades relacionadas siálicas.
|
|
US9487583B2
(en)
|
2011-03-30 |
2016-11-08 |
National University Corporation University Of Toyama |
Method for selecting plasma cells or plasmablasts, method for producing target antigen specific antibodies, and novel monoclonal antibodies
|
|
EP3228325A1
(en)
|
2011-06-10 |
2017-10-11 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
ES2682254T3
(es)
|
2011-08-18 |
2018-09-19 |
Affinity Biosciences Pty Ltd |
Polipéptidos solubles
|
|
WO2013033420A1
(en)
|
2011-08-30 |
2013-03-07 |
Whitehead Institute For Biomedical Research |
Methods of downregulating translocated oncogene expression using bromodomain inhibitors
|
|
CA2848410A1
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
CN104039809A
(zh)
|
2011-10-10 |
2014-09-10 |
希望之城公司 |
中间位和中间位结合抗体及其用途
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
EP2794658B1
(en)
|
2011-12-19 |
2017-03-15 |
Synimmune GmbH |
Bispecific antibody molecule
|
|
AU2013203422A1
(en)
|
2012-01-06 |
2013-07-18 |
Bioalliance C.V. |
Anti-transferrin receptor antibodies and methods using same
|
|
MX2014010183A
(es)
|
2012-02-22 |
2015-03-20 |
Univ Pennsylvania |
Composiciones y metodos para generar una poblacion persistente de celulas t utiles para el tratamiento de cancer.
|
|
JP2015512246A
(ja)
|
2012-03-15 |
2015-04-27 |
パーミオン バイオロジクス， インコーポレイテッド |
細胞内抗体および抗体様モイエティの送達のための細胞透過組成物ならびに使用方法
|
|
WO2013151649A1
(en)
|
2012-04-04 |
2013-10-10 |
Sialix Inc |
Glycan-interacting compounds
|
|
EP2885002A4
(en)
|
2012-08-14 |
2016-04-20 |
Ibc Pharmaceuticals Inc |
BISPECIFIC ANTIBODIES REDIRECTED AGAINST T CELLS FOR THE TREATMENT OF DISEASES
|
|
KR101796689B1
(ko)
|
2012-08-22 |
2017-11-10 |
재단법인 목암생명과학연구소 |
안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용
|
|
US9937205B2
(en)
|
2012-09-04 |
2018-04-10 |
The Trustees Of The University Of Pennsylvania |
Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
|
|
WO2014055771A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
|
WO2014093379A1
(en)
|
2012-12-10 |
2014-06-19 |
Mersana Therapeutics, Inc. |
Auristatin compounds and conjugates thereof
|
|
CA2896058A1
(en)
|
2012-12-24 |
2014-07-03 |
Abbvie Inc. |
Prolactin receptor binding proteins and uses thereof
|
|
EP2752487A1
(en)
|
2013-01-03 |
2014-07-09 |
Sanofi |
Intracellular phenotypic screening
|
|
US20160022829A1
(en)
|
2013-03-14 |
2016-01-28 |
Mersana Therapeutics, Inc. |
Tubulysin compounds and conjugates thereof
|
|
AU2014227638A1
(en)
|
2013-03-15 |
2015-09-17 |
Merck Patent Gmbh |
Tetravalent bispecific antibodies
|
|
BR112015022978A8
(pt)
|
2013-03-15 |
2018-01-23 |
Memorial Sloan Kettering Cancer Center |
tecnologias de multimerização
|
|
AU2014293116A1
(en)
|
2013-07-23 |
2016-02-18 |
Ohio State Innovation Foundation |
Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
|
|
WO2015048748A1
(en)
|
2013-09-30 |
2015-04-02 |
Board Of Regents, The University Of Texas System |
Myeloid-derived suppressor cell-specific peptides for diagnostic and therapeutic use
|
|
WO2015054600A2
(en)
|
2013-10-10 |
2015-04-16 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US10377990B2
(en)
|
2014-03-04 |
2019-08-13 |
Sigma-Aldrich Co. Llc |
Viral resistant cells and uses thereof
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
AU2015266958A1
(en)
|
2014-05-28 |
2016-12-08 |
Agenus Inc. |
Anti-GITR antibodies and methods of use thereof
|
|
TWI695011B
(zh)
|
2014-06-18 |
2020-06-01 |
美商梅爾莎納醫療公司 |
抗ｈｅｒ２表位之單株抗體及其使用之方法
|
|
MA40364A
(fr)
|
2014-08-27 |
2016-03-03 |
Oncomed Pharm Inc |
Polythérapie pour le traitement du cancer
|
|
WO2016057890A1
(en)
|
2014-10-10 |
2016-04-14 |
Siamab Therapeutics, Inc. |
Glycan analysis and profiling
|
|
WO2016057916A1
(en)
|
2014-10-10 |
2016-04-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
EP4183806A3
(en)
*
|
2014-11-12 |
2023-08-02 |
Seagen Inc. |
Glycan-interacting compounds and methods of use
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US20180334490A1
(en)
|
2014-12-03 |
2018-11-22 |
Qilong H. Wu |
Methods for b cell preconditioning in car therapy
|
|
EP4190817A1
(en)
|
2015-03-17 |
2023-06-07 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
EP3091032A1
(en)
|
2015-05-08 |
2016-11-09 |
Miltenyi Biotec GmbH |
Humanized antibody or fragment thereof specific for cd3
|
|
US20200041517A1
(en)
|
2015-06-12 |
2020-02-06 |
Seattle Genetics, Inc. |
Compositions and methods for targeting cancer stem cells
|
|
CN108463248B
(zh)
|
2015-11-12 |
2022-10-21 |
西雅图基因公司 |
聚糖相互作用化合物及使用方法
|
|
WO2017132486A1
(en)
|
2016-01-27 |
2017-08-03 |
Siamab Therapeutics, Inc. |
Compositions and methods for targeting cancer stem cells
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US20200247902A1
(en)
|
2016-11-17 |
2020-08-06 |
Seattle Genetics, Inc. |
Compositions and methods for treating cancer
|
|
WO2018160909A1
(en)
|
2017-03-03 |
2018-09-07 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|